No. 107

Kajang Selangor, Malaysia
Kajang Selangor, Malaysia
Time filter
Source Type

News Article | November 16, 2016

PLYMOUTH MEETING, Pa., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced it ranked No. 107 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2012 to 2015.  During this period Inovio’s revenue growth reached 885.1%, based on revenue received from grants, partnerships and licensing deals. Dr. J. Joseph Kim, Inovio's President and CEO, said, “We appreciate Deloitte’s recognition of Inovio’s growth based on our advancement of DNA immunotherapies and vaccines for cancers and infectious diseases.  Our growth is fueled by the innovative spirit of our scientists, engineers and business people.  At our company’s core; however, the Inovio team is motivated by our most important value: ‘Patients are waiting.’” “This year’s Fast 500 winners showcase that when organizations are open to diverse perspectives and insights, they are able to create an environment for their employees and investors to see the possibilities and ingenious solutions that might lie ahead,” added Jim Atwell, Deloitte’s national managing partner of the emerging growth practice. “Entrepreneurial environments foster change and innovation within businesses, and we look forward to watching these companies continue to drive change across all sectors.” Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2012 to 2015. Overall, 2016 Technology Fast 500™ companies achieved revenue growth ranging from 121 percent to 66,661 percent from 2012 to 2015, with median growth of 290 percent. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America. Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, The Wistar Institute, University of Pennsylvania, DARPA, GeneOne Life Science, Plumbline Life Sciences, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and Laval University. For more information, visit This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines, our expectations regarding our research and development programs and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs, including the Zika vaccine GLS-5700, the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immunotherapy and vaccine products, the ability of our collaborators to attain development and commercial milestones for products we license and product sales that will enable us to receive future payments and royalties, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost effective than any therapy or treatment that the company and its collaborators hope to develop, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2015, our Form 10-Q for the quarter ended September 30, 2016, and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

News Article | December 5, 2016

Insurance Providers Partner to Protect Students and Help Colleges RICHMOND, VA--(Marketwired - December 05, 2016) - Allianz Global Assistance, a leading consumer specialty insurance provider and GradGuard™, a leading provider of student protection programs at more than 200 colleges and universities, have formed a partnership to provide Allianz Tuition Insurance to higher education institutions across the nation. The companies are working together to protect the nearly $500 billion investment that 21 million college students or their parents make annually in higher education. Allianz Tuition Insurance provides a practical way for families to safeguard their tuition in case a student must withdraw from school due to a reason covered by the policy, such as a covered illness or injury. Allianz Tuition Insurance also helps schools provide a better withdrawal experience for students by providing reimbursement when schools may not. Allianz Tuition Insurance offers a range of plans to protect both in-state and out-of-state non-refundable college tuition, housing and other fees in the event that a student withdraws from school for a covered illness, injury, psychological/mental disorder, or other reasons. One of the plans provides coverage for almost any unforeseen reason that may cause a student to leave school.* Allianz Tuition Insurance must be purchased prior to the first day of the semester and three different plans are available, starting at only $29.95 per semester. The insurance also includes Allianz Global Assistance's proprietary Student Life Assistance, a 24/7 service that assists families in the event of an emergency. A recent survey of financial advisors conducted by an independent firm and commissioned by Allianz reports that nearly eight in 10 (78 percent) financial advisors say they would recommend tuition insurance for students taking out loans while more than seven in 10 (72 percent) say they would recommend it for first-year college students. "College tuition is one of the largest investments that consumers will make in their lifetime," said Joe Mason, chief marketing officer of Allianz Global Assistance USA. "A significant number of students will have to leave school unexpectedly due to an illness, injury or serious psychological issue sometime during their college career. Allianz Tuition Insurance can refund lost tuition and fees, offering students a financial lifeline and colleges with a student-friendly solution for withdrawals." "Working closely with Allianz Global Assistance will help GradGuard fulfill our mission to protect the investment that students and families make in higher education," said John Fees, co-founder of GradGuard™. "We are confident that colleges and universities and the families they serve will be pleased with the innovative approach that Allianz Tuition Insurance brings to helping students protect their investment in a higher education." GradGuard, a service of Next Generation Insurance Group LLC, is a leading provider of student protection programs at more than 200 colleges and universities and an authority at designing and implementing student benefit programs that help schools to attract and retain students. Since 2008, GradGuard's tuition and renters insurance programs have helped more than 600,000 students protect their investment in a higher education. Please visit to learn more about how we fulfill our mission to protect the investment students and their families are making in a higher education. Learn more at Allianz Global Assistance USA (AGA Service Company) is a leading consumer specialty insurance and assistance company. We serve 21 million customers annually and are best known for our Allianz Travel Insurance plans. In addition to travel insurance, Allianz Global Assistance USA offers tuition insurance, event ticket protection, registration protection for endurance events and unique travel assistance services such as international medical assistance and concierge services. The company also serves as an outsource provider for in-bound call center services and claims administration for property and casualty insurers and credit card companies. To learn more about Allianz Tuition Insurance, visit or call 1.888.427.5045. Like us on Facebook at *Terms, conditions, and exclusions apply. Plans are available only to U.S. residents. Not all plans are available in all jurisdictions. For a complete description of the coverage and benefit limits offered under your plan, carefully review your declarations page and Certificate of Insurance/Policy. Insurance coverage is underwritten by Jefferson Insurance Company (NY, Administrative Office: Richmond, VA), rated "A+" (Superior) by A.M. Best Co., under Jefferson Form No. 107-P series. Allianz Global Assistance and Allianz Tuition Insurance are brands of AGA Service Company. AGA Service Company is the licensed producer and administrator of these plans and an affiliate of Jefferson Insurance Company. The insured shall not receive any special benefit or advantage because of the affiliation between AGA Service Company and Jefferson Insurance Company. Non-insurance benefits/products are provided and serviced by AGA Service Company.

Salih A.M.,University Putra Malaysia | Salih A.M.,Sudan Atomic Energy Commission | Ahmad M.B.,University Putra Malaysia | Ibrahim N.A.,University Putra Malaysia | And 4 more authors.
Molecules | Year: 2015

Over the past few decades, there has been an increasing demand for bio-based polymers and resins in industrial applications, due to their potential lower cost and environmental impact compared with petroleum-based counterparts. The present research concerns the synthesis of epoxidized palm oil acrylate (EPOLA) from an epoxidized palm oil product (EPOP) as environmentally friendly material. EPOP was acrylated by acrylic acid via a ring opening reaction. The kinetics of the acrylation reaction were monitored throughout the reaction course and the acid value of the reaction mixture reached 10 mg KOH/g after 16 h, indicating the consumption of the acrylic acid. The obtained epoxy acrylate was investigated intensively by means of FTIR and NMR spectroscopy, and the results revealed that the ring opening reaction was completed successfully with an acrylation yield about 82%. The UV free radical polymerization of EPOLA was carried out using two types of photoinitiators. The radiation curing behavior was determined by following the conversion of the acrylate groups. The cross-linking density and the hardness of the cured EPOLA films were measured to evaluate the effect of the photoinitiator on the solid film characteristics, besides, the thermal and mechanical properties were also evaluated.

Zhang C.H.,No. 107 | Xi X.L.,Yantai University | Liu S.T.,No. 107 | Shao L.J.,No. 107 | Hu X.H.,No. 107
Science China Earth Sciences | Year: 2014

Mesoscale eddies exist almost everywhere in the ocean and play important roles in the ocean circulation of the world. These eddies may cause sound spread singular regions and bring great influences to the upwater ship and underwater aircraft. Due to the lack of hydrographic survey datasets, study of mesoscale eddies has been greatly restricted. Fortunately, satellite altimeter provided an effective way to study mesoscale eddies. An automatic detection algorithm is introduced to detect mesoscale eddies of specific intensity and spatial/temporal scale based on satellite sea surface height (SSH) data and the algorithm is applied in a strong eddy activity region: the South China Sea and the Northwest Pacific. The algorithm includes four steps. The first step is preprocessing of the SSH image, which includes elimination of error SSH data and interpolation. The second step is to detect suspected mesoscale eddies from preprocessed SSH images by dynamic threshold adjustment and morphological method, and the suspected mesoscale eddy detection includes two procedures: suspected mesoscale eddy core region detection and suspected mesoscale eddy brim extraction. The third step is to pick out mesoscale eddies satisfied with specified criteria from suspected mesoscale eddies. The criteria include three items, that is, intensity criterion, spatial scale, criterion and temporal scale criterion. The last step is algorithm performance analysis and verification. The algorithm has the capability of adaptive parameter adjustment, and can extract mesoscale eddies of interested intensity and spatial/temporal scale. The paper can provide a basis for analyzing space-time characteristics of mesoscale eddy in the South China Sea and the Northwest Pacific. © 2014 Science China Press and Springer-Verlag Berlin Heidelberg.

Loading No. 107 collaborators
Loading No. 107 collaborators